Skip to Content

CERNEVIT INJECTION

Active substance(s): ASCORBIC ACID / COCARBOXYLASE TETRAHYDRATE / COLECALCIFEROL / CYANOCOBALAMIN / DEXPANTHENOL / DL-ALPHA TOCOPHEROL / FOLIC ACID / NICOTINAMIDE / PYRIDOXINE HYDROCHLORIDE / RETINOL PALMITATE / RIBOFLAVIN DIHYDRATED SODIUM PHOSPHATE

View full screen / Print PDF » Download PDF ⇩
Transcript
N/A

N/A

N/A

Name

Signature

Date

DATE
PLANT APPROVAL
HALLE ONLY
N/A
Country

RA TO APPROVE LAYOUT
AND FORMAT
2nd DRAFT

ARTWORK APPROVAL

PR2:
PR1:

Comments:

BE-30-02-467

Errors: Yes/No

1

Size
Text
Format
Barcode(s)
Edge Code
BGS Y N NA
Trademark Y N NA
Sign...........................:
Date...........................:

CERNEVIT is a powder for solution for injection or infusion. It contains
12 vitamins (see Section 6).
CERNEVIT is used to give your daily requirement of vitamins straight into
your blood. It is used when you cannot take enough food by your mouth. It is
usually given with other things such as nutrition solutions and minerals.

Draft: 2nd

1 What CERNEVIT is and what it is used for

Date: 28 JAN 2016

Throughout this leaflet CERNEVIT Powder for Solution for Injection or
Infusion will be called CERNEVIT.

Version: 01

In this leaflet:
1 What CERNEVIT is and what it is used for
2 What you need to know before CERNEVIT is given
3 How CERNEVIT is given
4 Possible side effects
5 How to store CERNEVIT
6 Contents of the pack and other information

Artworker: Kris Rackham

Read all of this leaflet carefully before this medicine is given to you
because it contains important information for you.
• Keep this leaflet. You may need to read it again.
• If you have any further questions, ask your doctor, nurse or pharmacist.
• If you get any side effects, talk to your doctor, nurse or pharmacist. This
includes any possible side effects not listed in this leaflet. See section 4.

ARTWORK DESIGN CENTRE

PACKAGE LEAFLET:
INFORMATION FOR THE PATIENT
CERNEVIT Powder for Solution
for Injection or Infusion

EMEA ARTWORK DESIGN CENTRE

b

N/A

N/A

N/A

Name

Signature

Date

DATE
PLANT APPROVAL
HALLE ONLY
N/A
Country

RA TO APPROVE LAYOUT
AND FORMAT
2nd DRAFT

Date:
Sign:

ARTWORK APPROVAL

Date:

BE-30-02-467

Sign:

2

Version: 01

You will NOT be given CERNEVIT if:
• you are allergic (hypersensitive) to any of the ingredients in CERNEVIT,
especially vitamin B1 or soy protein, (see Section 6),
• you have too much of one of the vitamins in CERNEVIT stored in your body
(called ‘hypervitaminosis’).
Do not have CERNEVIT if any of the above applies to you. If you are not sure
talk to your doctor, nurse or pharmacist.
Your doctor will take special care with CERNEVIT if:
• you are having vitamin A (retinol) from other sources
• you have kidney problems. In this case your doctor will carefully monitor
your fat-soluble vitamin levels. The fat-soluble vitamins are A, D, E and K
• you have liver disease. Your doctor will do blood tests to check how well
your liver is working. They will monitor the levels of certain ‘enzymes’ in
your liver.
If you are not sure if any of the above applies to you, talk to your doctor,
nurse or pharmacist before being given CERNEVIT.
Your doctor will make sure that:
• you are given additional vitamin K if you need it. CERNEVIT does not
contain vitamin K
• your body has all that it needs for good health. If necessary, you may also
be given minerals, amino acids (the building blocks of protein), fatty acids
(the building blocks of fats), electrolytes (salts) and sugar solutions (such
as glucose).
Using other medicines
Please tell you doctor, nurse or pharmacist if you are taking or have recently
taken any other medicines. This includes medicines obtained without a
prescription, including herbal medicines.
This is because some of the ingredients in CERNEVIT can affect the way
some medicines work.
In particular tell your doctor, nurse or pharmacist if you are taking any of the
following medicines.
• Levodopa (a medicine used for Parkinson’s disease). The vitamin B6
(pyridoxine) in CERNEVIT can affect this medicine

EMEA ARTWORK DESIGN CENTRE

2 What you need to know before CERNEVIT is given

N/A

N/A

N/A

Name

Signature

Date

DATE
PLANT APPROVAL
HALLE ONLY
N/A
Country

RA TO APPROVE LAYOUT
AND FORMAT
2nd DRAFT

ARTWORK APPROVAL

EMEA ARTWORK DESIGN CENTRE

Date:

BE-30-02-467

Sign:

3

Date:

CERNEVIT will be given to you by a doctor or nurse.
How CERNEVIT is given
• The CERNEVIT powder will first be dissolved with a liquid such as ‘sterile
water for injection’. This will be mixed with a larger volume of fluid before
it is given to you.
• It will be given into a vein as a drip (slow intravenous infusion) over at
least ten minutes.
• CERNEVIT can also be added to other nutrition solutions. This mixed
nutrition solution will be given to you as a drip into your vein.
The recommended dose
Your doctor will decide how much CERNEVIT you should be given. The
amount you will be given depends upon your age, weight and the reason you
are being given the medicine.
• Adults and children over 11 years: the recommended dose is one vial
(small glass bottle) of CERNEVIT each day.
• Children under 11 years: not recommended.

Sign:

3 How CERNEVIT is given

Version: 01

• Phenobarbital, phenytoin and/or primidone (used in epilepsy for fits
or convulsions and sometimes for other conditions). The folic acid in
CERNEVIT may interact with these medicines.
Your doctor may monitor the levels of these medicines in your blood and may
have to adjust their dose when you start or stop taking CERNEVIT.
Tests while you are having CERNEVIT
If you are due to have a blood test, tell your doctor you are having CERNEVIT.
The folic acid in CERNEVIT may stop the detection of a problem called
‘pernicious anaemia’. This is when you have a drop in red blood cells
because your body cannot properly absorb vitamin B12 from your gut.
Important Information about some of the ingredients of CERNEVIT
CERNEVIT contains 24 mg sodium (1 mmol) per vial. This should be taken into
consideration by patients on a controlled sodium diet.
Pregnancy and breast-feeding
If you are pregnant, think you might be pregnant or are breast-feeding, tell
your doctor. They will decide if you can have CERNEVIT.

N/A

N/A

N/A

Name

Signature

Date

DATE
PLANT APPROVAL
HALLE ONLY
N/A
Country

RA TO APPROVE LAYOUT
AND FORMAT
2nd DRAFT

ARTWORK APPROVAL

EMEA ARTWORK DESIGN CENTRE

Date:

BE-30-02-467

Sign:

4

Date:

Like all medicines, CERNEVIT can cause side effects, although not everybody
gets them. The following side effects may happen with this medicine.
The following side effect is common and could affect 1 to 10 users in 100:
- Pain at the site of injection
The following side effects are uncommon and could affect 1 to 10 users in
1,000:
- Feeling sick (nausea),
- being sick (vomiting)
The following side effects have been reported at an unknown frequency:
- Allergic reactions, with respiratory difficulties, chest pain, tightening of
the throat, urticaria, rash, skin redness, abdominal discomfort, as well as
cardiac arrest
- Increased levels of vitamin A and vitamin A carrier protein in blood
- Taste alteration (metallic taste)
- Accelerated heart rate
- Accelerated breathing rate

Sign:

4 Possible side effects

Version: 01

If you are given too much
Your doctor or nurse will give you CERNEVIT so it is unlikely you will be given
too much. If you are worried that you have had too much, tell your doctor or
nurse.
Signs of overdose of CERNEVIT are mostly the signs of overdose of vitamin A:
• Signs of sudden overdose of vitamin A include:
- gastrointestinal disorders (nausea, vomiting),
- nervous system disorders (headache, swelling of the optic nerve,
convulsions) due to an increased pressure in your head,
- psychiatric disorders (irritability),
- skin disorders (delayed peeling of the skin).
• Signs of long-term overdose of vitamin A include:
- headache due to an increased pressure in your head,
- bone disorders (tender or painful swellings at the ends of your limbs).
If you notice any of these signs of overdose, tell your doctor or nurse. They
may stop your CERNEVIT infusion.

N/A

N/A

N/A

Name

Signature

Date

DATE
PLANT APPROVAL
HALLE ONLY
N/A
Country

RA TO APPROVE LAYOUT
AND FORMAT
2nd DRAFT

ARTWORK APPROVAL

EMEA ARTWORK DESIGN CENTRE

Date:

BE-30-02-467

Sign:

5

Date:

Because CERNEVIT is usually given in hospital it will be stored safely and
correctly by the hospital staff. If you do need the storage conditions they are
given below.
• Keep this medicine out of the sight and reach of children.
• CERNEVIT will not be used after the expiry date that is stated on the label
after ‘EXP’. The expiry date refers to the last day of that month.
• Do not store above 25ºC.
• Store in the outer carton in order to protect from light.
• CERNEVIT should not be used if the solution is not clear, or if the vial is
damaged in any way.
• Once CERNEVIT has been mixed with water it should not be kept for more
than 24 hours.
• Partly used vials should not be used again. Any left-over CERNEVIT should
be thrown away safely by a healthcare professional.
• All equipment used will be disposed of safely by a healthcare professional
after use.

Sign:

5 How to store CERNEVIT

Version: 01

- Diarrhoea
- Increase in level of liver enzymes and bile acid
- Pruritus (itching)
- Fever, generalized soreness, reactions at the site of infusion such as
burning sensation, rash.
If you show any symptom of an allergic reaction such as respiratory
difficulties, chest pain, tightening of the throat, urticaria, rash, skin redness,
abdominal discomfort, inform a doctor or nurse immediately. They will stop
the infusion and conduct the necessary emergency measures.
If you get any side effects, talk to your doctor, nurse or pharmacist. This
includes any possible side effects not listed in this leaflet. You can also report
side effects directly (see details below). By reporting side effects you can
help provide more information on the safety of this medicine.

Yellow Card Scheme
www.mhra.gov.uk/yellowcard

6

BE-30-02-467

Version: 01

For information about CERNEVIT or to request this leaflet in
formats such as audio or large print please contact the Marketing
Authorisation Holder: Tel: 01635 206345.
Baxter and Cernevit are trademarks of Baxter International Inc.

N/A

N/A

N/A

Name

Signature

Date

DATE
PLANT APPROVAL
HALLE ONLY
N/A
Country

RA TO APPROVE LAYOUT
AND FORMAT
2nd DRAFT

ARTWORK APPROVAL

Date:
Sign:

• The other ingredients are glycine, glycocholic acid and soybean
phosphatides. It may also contain small amounts of sodium hydroxide or
hydrochloric acid for pH adjustment.
What CERNEVIT looks like and the contents of the pack
CERNEVIT is a powder for solution for injection or infusion. It is an orangeyellow cake of powder supplied in brown glass vials. It is packaged in
cartons containing 1, 10 or 20 vials. Not all pack sizes may be marketed.
Marketing Authorisation Holder and Manufacturers
The Marketing Authorisation holder is:
Baxter Healthcare Ltd
Caxton Way, Thetford, Norfolk, IP24 3SE
United Kingdom
Send all enquiries to this address.
CERNEVIT is made at:
Baxter S.A.
Bd. R. Branquart 80, B-7860 Lessines
Belgium
This leaflet was last revised 01/2016.

Date:

IU = International Units
mg = milligrams

Sign:

What CERNEVIT contains
• The active substances are retinol palmitate (vitamin A) 3500 IU,
colecalciferol (vitamin D3) 220 IU, DL--tocopherol (vitamin E) 10.20 mg,
ascorbic acid (vitamin C) 125 mg, cocarboxylase tetrahydrate (vitamin B1)
5.80 mg, riboflavin dehydrated sodium phosphate (vitamin B2) 5.67 mg,
pyridoxine hydrochloride (vitamin B6) 5.50 mg, cyanocobalamin (vitamin
B12) 6 µg, folic acid 414 µg, dexpanthenol 16.15 mg, D-Biotin 69 µg,
nicotinamide (vitamin PP) 46 mg per vial.

EMEA ARTWORK DESIGN CENTRE

6 Contents of the pack and other information

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide